Who owns ESPERION THERAPEUTICS INC NE?
- CUSIP Number: 29664wab1
Tip: Access positions for across all investors
Analyze quarterly positions in Esperion Therapeutics Inc Ne with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Esperion Therapeutics Inc Ne stock
Who bought or sold ESPERION THERAPEUTICS INC NE this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
PenderFund Capital Management | 41M | $33M | 0% | Dec 2023 |
|
Pentwater Capital Management | 34M | $20M | -27% | Dec 2023 |
|
Davidson Kempner Capital Management | 33M | $19M | 6% | Dec 2023 |
|
Highbridge Capital Management | 22M | $13B | 0% | Dec 2023 |
|
Tenor Capital Management | 19M | $11B | 0% | Dec 2023 |
|
Context Capital Management | 18M | $11B | 99900% | Dec 2023 |
|
Whitebox Advisors | 17M | $9.7M | 0% | Dec 2023 |
|
Readystate Asset Management | 5.5M | $3.3M | 0% | Dec 2023 |
|
Whitefort Capital Management | 4.9M | $2.8M | 100% | Dec 2023 |
|
Point72 Asset Management | 4.5M | $2.6M | 50% | Dec 2023 |
|
Capstone Investment Advisors | 2.5M | $1.5M | 0% | Dec 2023 |
|
HN Saltoro Capital | 1.0M | $593k | 0% | Dec 2023 |
|
Ingalls & Snyder | 933k | $544k | 0% | Dec 2023 |
|